First ResearchKit health app released in UK, Hong Kong

click to enlargeOn Thursday, Stamford University released MyHeartCounts, the first iPhone health app using the Apple ResearchKit platform. Initial launch is in the UK and Hong Kong. It is designed to study factors around heart health by collecting data about physical activity and cardiac risk factors. Every three months, participants monitor one week’s worth of physical activity and also complete a 6-minute walk fitness test. The latest version of the app also includes feedback on users’ behaviors and risks. While the initial phase of the MyHeart Counts study both collects heart health data and provides personalized information to participants, the next phase will be to study motivational tools for users. Currently 41,000 participants have registered for this study. Medaxs via eHealthSpace.org (both Australia)

ELabNYC Pitch Day 2015

Thursday 3 April, Microsoft’s NY Technology Center, Times Square NYC

click to enlargeThe third annual Pitch Day for the now 20 startup/early-stage life science, biotech and healthcare technology companies in the ELabNYC (Entrepreneurship Lab Bio and Health Tech NYC) is a culmination of their year-long program participation in this NY Economic Development Corporation (NYCEDC)-supported program. The entrepreneurs in the ELabNYC program primarily come from from the doctoral and post-doc programs from New York’s many universities, from CUNY to Columbia, from many parts of the world, and most have experience within the city’s multitude of major health research institutions from The Bronx to Brooklyn. New York is also a center of funding for life science and health tech ventures; it’s #2 with NIH awards totaling $1.4 billion. For the past few years, NYEDC has also supported these companies with finding access to capital, specialized space (e.g. wet labs such as the million square feet at Alexandria Center alone, plus Harlem Biospace and SUNY Downstate in Brooklyn) and partnerships with major companies such as Celgene, Eli Lilly, Pfizer and GE Ventures.

This Editor will concentrate on health tech companies–eight, up from five last year [TTA 17 Apr 14]. Each company pitched for five minutes on its concept, its current state of advancement (including pilots/customers), its team and a funding timeline. It was a very different mix from last year’s class, which focused on compliance, diagnosis, dementia and concussion. These companies focused on niches which are either not being served well or to substantially reduce costs. Nearly half the entrepreneurs were women, a substantially greater number than one usually sees in the biotech/health tech area. Short impressions on our eight, with links to their Executive Summaries on the 2014-15 ‘class page’: (more…)